| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 4 |
| 1 | BISOPROLOL FUMARATE | 4 |
| 2 | ADALIMUMAB-AATY | 3 |
| 3 | ADALIMUMAB-ADAZ | 3 |
| 4 | ADALIMUMAB-FKJP | 3 |
| 5 | MESALAMINE | 3 |
| 6 | MIRTAZAPINE | 3 |
| 7 | ASPIRIN | 2 |
| 8 | ASPIRIN 325 MG | 2 |
| 9 | ASPIRIN 81 MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MOGAMULIZUMAB-KPKC | 1 | 0.0007 |
| 1 | VINBLASTINE SULFATE | 1 | 0.0005 |
| 2 | LARONIDASE | 2 | 0.0005 |
| 3 | FLUDROCORTISONE ACETATE | 1 | 0.0004 |
| 4 | ETRAVIRINE | 1 | 0.0002 |
| 5 | NORGESTIMATE AND ETHINYL ESTRADIOL | 1 | 0.0002 |
| 6 | RALTEGRAVIR | 1 | 0.0002 |
| 7 | DACARBAZINE | 1 | 0.0001 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 9 | MESALAMINE | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Aminosalicylate [EPC] | 3 | 0.0000 |
| 4 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 5 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Muscle Relaxant [EPC] | 1 | 0.0000 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Cholinergic Nicotinic Agonist [EPC] | 1 | 0.0000 |
| 9 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |